Not finding it? Sign in to also search OpenAlex live.
-
PD-1 blockade does not enhance alloimmunization after allogeneic dendritic cell vaccination in cancer patients2026 Frontiers in Immunology article Immunology and Microbiology Immunotherapy and Immune Responses Open access
Séverine Planel, Guillaume Vayssière, Gianni Maggipinto, Estelle Leplus, Karine Laulagnier, Françoise Myster, +21 more
0citations -
Identifying Pregnancies at Higher Risk for HPA-1a Alloimmunization and Fetal/Neonatal Alloimmune Thrombocytopenia (FNAIT): An International, Prospective, Natural History Study
Emilie Vander Haar, Courtney Abshier Ware, Gwen Allen, Róisín Armstrong, Michael Bombara, David N. Dhanraj, +12 more
2citations -
RhD alloimmunization in pregnancy and hemolytic disease of the fetus and newborn in Africa: A systematic review and meta-analysis2025 Best Practice & Research Clinical Obstetrics & Gynaecology review Medicine Blood groups and transfusion Open access
Assefa Desalew, Rafiki Nickson Mjema, Henk Schonewille, C. Ellen van der Schoot, Derek P. de Winter, Thomas van den Akker, +19 more
2citations -
Extensive red blood cell matching considering patient alloimmunization risk2024 Vox Sanguinis article Business, Management and Accounting Blood donation and transfusion practices Open access
Merel L. Wemelsfelder, Ronald H. G. van de Weem, Jessie S. Luken, Masja de Haas, René W L M Niessen, C. Ellen van der Schoot, +4 more
8citations -
Should HLA and HPA‐matched platelet transfusions for patients with Glanzmann Thrombasthenia or Bernard‐Soulier syndrome be standardized care? A Dutch survey and recommendations
Elise J. Huisman, Nory Holle, Martin Roelof Schipperus, Marjon H. Cnossen, Masja de Haas, Leendert Porcelijn, +1 more
11citations -
Real‐world performance of a clinical droplet digital polymerase chain reaction assay for non‐invasive foetal blood group and platelet antigen genotyping of alloimmunized pregnant women with antibodies directed against RhD , RhE , Rhc, RhC , K1 , HPA ‐1a or HPA ‐5b: A 1‐year experience
Camilla Calandrini, Onno J. H. M. Verhagen, Ahmed Tissoudali, Christa Homburg, Jessica Vessies, Mark Brussee, +3 more
8citations -
Cost‐effectiveness of cEK ‐preventive matched transfusion strategies for female transfusion recipients to prevent haemolytic disease of the foetus and newborn in the Dutch healthcare setting
Jessie S. Luken, Amy Bouman, Claudia C. Folman, Masja de Haas, Elske M. E. van den Akker‐van Marle
1citations -
Reduction of anti‐K‐mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: A nation‐wide policy change evaluation study in the Netherlands
Jessie S. Luken, Claudia C. Folman, Michaël V. Lukens, Johan H. Meekers, Peter C. Ligthart, Henk Schonewille, +5 more
23citations -
Altered Fc glycosylation of anti‐HLA alloantibodies in hemato‐oncological patients receiving platelet transfusions2022 Journal of Thrombosis and Haemostasis article Medicine Blood groups and transfusion Open access
Thijs L. J. van Osch, Tamás Pongrácz, Dionne M. Geerdes, Juk Yee Mok, Wim J.E. van Esch, Jan Voorberg, +8 more
13citations -
Mapping anticipated advantages and disadvantages of implementation of extensive donor genotyping: A focus group approach2022 Transfusion Medicine article Business, Management and Accounting Blood donation and transfusion practices Open access
Jessie S. Luken, Sebastien P. Ritsema, Merel M. van der Wal, C. Ellen van der Schoot, E.A.J.A. Rouwette, Masja de Haas, +1 more
8citations